![](https://i.imgur.com/CLvY2jA.png")
30-04-2022, 12:12 PM
Germany’s vaccine commission recommended that people under 30 and pregnant women should get the Pfizer Inc. and BioNTech SE COVID shot rather than one from Moderna Inc.
Rare heart-inflammation side effects appear more common with Moderna’s shot in younger patients, the commission said.
The German call follows a similar recent move in France, where health officials recommended using the Pfizer-BioNTech shot, whenever possible, in the under-30 population. The officials, however, noted that the Moderna shot appears to have a slightly higher efficacy and can be used for those 30 and up for initial vaccine rounds and in half-dose form for boosting purposes.
Moderna has yet to gain U.S. clearance for its vaccine for 12-to 17-year-olds. Regulators have said they need more time to examine the risk of myocarditis, a rare form of heart inflammation, before deciding on clearing it for that age group.
https://fortune.com/2021/11/10/germany-c...r-moderna/
Rare heart-inflammation side effects appear more common with Moderna’s shot in younger patients, the commission said.
The German call follows a similar recent move in France, where health officials recommended using the Pfizer-BioNTech shot, whenever possible, in the under-30 population. The officials, however, noted that the Moderna shot appears to have a slightly higher efficacy and can be used for those 30 and up for initial vaccine rounds and in half-dose form for boosting purposes.
Moderna has yet to gain U.S. clearance for its vaccine for 12-to 17-year-olds. Regulators have said they need more time to examine the risk of myocarditis, a rare form of heart inflammation, before deciding on clearing it for that age group.
https://fortune.com/2021/11/10/germany-c...r-moderna/
